Trademark Overview
On Tuesday, May 6, 2025, a trademark application was filed for MINARIS ADVANCED THERAPIES with the United States Patent and Trademark Office. The USPTO has given the MINARIS ADVANCED THERAPIES trademark a serial number of 99171879. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 6, 2025. This trademark is owned by Minaris Advanced Therapies, LLC. The MINARIS ADVANCED THERAPIES trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; information, advice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapies, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration
Medical services, namely, contracted cell culturing and tissue culturing for medical purposes; medical advisory services, namely, advisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical services, namely, separation and cultivation of body tissues and cells for medical purposes; information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; isolation, collection and preservation of blood components including cells or stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, and cells of human or animal origin
Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory...
